journal article·2025-09-02Open access

Elevated Parathyroid Hormone Levels Are Associated with Increased Risk of Arteriovenous Fistula Thrombosis in Hemodialysis Patients: Findings from a 5-Year Cohort Study

Marcel Palamar, Iulia Dana Grosu, Adalbert Schiller, Ligia Petrica, Oana Stirbu, Madalina Bodea, Alexandru Sircuta, Maria Daniela Tanasescu, Flaviu Bob

Applied Sciences· Volume 15· Issue 17

Abstract

(1) Background: Arteriovenous fistula (AVF) thrombosis represents a major cause of vascular access failure in patients undergoing maintenance hemodialysis. Identifying early biochemical markers associated with thrombosis may facilitate timely intervention and improve vascular outcomes. This study aimed to evaluate the association between baseline biochemical markers and the risk of AVF thrombosis and mortality during long-term follow-up. (2) Methods: We conducted a prospective observational study involving 249 chronic hemodialysis patients with functional AVFs. Baseline data included intact parathyroid hormone (iPTH), hemoglobin, phosphate, potassium, albumin, dialysis adequacy (Kt/V), age, diabetes status, and antivitamin K (AVK) therapy. Patients were followed for five years for the occurrence of AVF thrombosis and mortality. Statistical analysis was performed using one-way ANOVA with Levene’s test and Scheffé post hoc comparisons. (3) Results: iPTH levels were significantly higher in patients who developed AVF thrombosis (mean 494.6 pg/mL) than in those without thrombosis (mean 381.5 pg/mL; p = 0.047). Other variables, including hemoglobin, phosphate, Kt/V, age, diabetes, and AVK therapy, were not significantly associated with thrombosis. Mortality was more frequent among patients with diabetes mellitus and those receiving antivitamin K therapy; however, only the association with diabetes reached statistical significance. (4) Conclusions: Elevated iPTH was associated with AVF thrombosis. Routine monitoring may help identify high-risk patients and guide timely interventions.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Central Venous Catheters and Hemodialysis · Vascular Procedures and Complications · Cardiac Arrhythmias and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Deva Emergency County Hospital, 330004 Deva, Romania

Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania

Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, County Emergency Hospital Timisoara, 300041 Timisoara, Romania

Department of Nephrology and Dialysis, Arad County Hospital, 310158 Arad, Romania

B Braun Avitum Dialysis Centre, 300417 Timisoara, Romania

Department of Nephrology, Bucharest Emergency University Hospital, 050098 Bucuresti, Romania

Funding

University of Medicine and Pharmacy “Victor Babes” Timisoara, Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, and “Victor Babes” University of Medicine and Pharmacy, Timișoara, Romania

References (40)

Show source-provided references
1. Most Important Chronic Complications of Arteriovenous Fistulas for Hemodialysis10.1159/000343669 ↗
2. Complications of the Arteriovenous Fistula: A Systematic Review
3. The Positive Association of Homocysteine (Hcy) with Arteriovenous Fistula Thrombosis (AVFT) in Chinese Patients on Hemodialysis: A Retrospective Cohort Study10.1016/j.avsg.2025.02.024 ↗
4. The Society for Vascular Surgery: Clinical Practice Guidelines for the Surgical Placement and Maintenance of Arteriovenous Hemodialysis Access10.1016/j.jvs.2008.08.042 ↗
5. Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study10.1016/j.xkme.2022.100456 ↗
6. Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial10.1093/ckj/sfz048 ↗
7. Meta-Analysis of Risk Factors for Arteriovenous Fistula Thrombosis in Hemodialysis Patients10.1159/000526768 ↗
8. Risk Factors for Thrombosis in Dialysis Patients: A Comprehensive Systematic Review and Meta-Analysis10.1016/j.jvn.2024.05.002 ↗
9. Parathyroid Hormone Induces Transition of Myofibroblasts in Arteriovenous Fistula and Increases Maturation Failure10.1210/endocr/bqab044 ↗
10. Chinese Experts Group of the Guideline for the Management of ‘CKD-PeriDialysis’, and Chinese Non-Government Medical Institutions Association (2022). Chinese Clinical Practice Guideline for the Management of “CKD-PeriDialysis”—The Periods Prior to and in the Early-Stage of Initial Dialysis. Kidney Int. Rep., 7, S531–S558.10.1016/j.ekir.2022.10.001 ↗
11. Factors associated with dysfunction of autogenous arteriovenous fistula in patients with secondary hyperparathyroidism after parathyroidectomy10.1080/0886022X.2024.2402515 ↗
12. Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study10.1016/j.jvs.2015.07.086 ↗
13. Analysis of risk factors for late arteriovenous fistula failure and patency rates after angioplasty in hemodialysis patients: A retrospective cohort study10.21037/tau-23-431 ↗
14. Obesity-related decrease in intraoperative blood flow is associated with maturation failure of radiocephalic arteriovenous fistula10.1016/j.jvs.2015.05.008 ↗
15. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis10.1046/j.1523-1755.2003.00120.x ↗
16. The mechanisms of hyperphosphatemia-induced vascular calcification10.1177/039139880803101203 ↗
17. Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease10.1038/ki.2012.69 ↗
18. Lee, S.J., Lee, I.-K., and Jeon, J.-H. (2020). Vascular Calcification—New Insights into Its Mechanism. Int. J. Mol. Sci., 21.10.3390/ijms21082685 ↗
19. The association of demographic, clinical, and thrombophilic factors with the failure of arteriovenous fistula among hemodialysis patients
20. The role of mineral metabolism and inflammation on dialysis vascular access failure10.1177/112972980600700207 ↗
21. Risk factors of vascular access failure in patients on hemodialysis
22. Arteriovenous Fistula Thrombosis in Patients on Regular Hemodialysis: A Report of 171 Patients
23. Increasing Arteriovenous Fistulas in Hemodialysis Patients: Problems and Solutions10.1111/j.1523-1755.2002.kid551.x ↗
24. Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial10.1001/jama.299.18.2164 ↗
25. Clinical Outcomes and Quality of Life in Hemodialysis Diabetic Patients versus Non-Diabetics10.15171/jnp.2017.14 ↗
26. Song, Y.H., Cai, G.Y., Xiao, Y.F., and Chen, X.M. (2020). Risk Factors for Mortality in Elderly Haemodialysis Patients: A Systematic Review and Meta-Analysis. BMC Nephrol., 21.10.1186/s12882-020-02026-x ↗
27. The Association of Diabetes with All-Cause Mortality in Patients with End-Stage Renal Disease Compared to the General Population in Poland—A Comparative Analysis
28. Risk Factors Associated with All-Cause Death Among Dialysis Patients with Diabetes10.12659/MSM.930152 ↗
29. Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients10.1681/ASN.2008080824 ↗
30. Warfarin Use in Hemodialysis Patients with Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes10.1177/2054358117735532 ↗
31. Atrial Fibrillation in Hemodialysis Patients: Clinical Features and Associations with Anticoagulant Therapy10.1038/ki.2009.477 ↗
32. Vitamin K Antagonists for Stroke Prevention in Hemodialysis Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis10.1016/j.ahj.2016.09.016 ↗
33. Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients with Atrial Fibrillation on Dialysis10.1016/j.amjcard.2016.03.042 ↗
34. Long-Term Anticoagulation for Patients Receiving Dialysis: Tilting the Benefit-to-Risk Ratio?10.1161/CIRCULATIONAHA.118.037091 ↗
35. Hypoproteinemia as a Prognostic Risk Factor for Arteriovenous Fistula Failure10.1111/hdi.12538 ↗
36. Reassessing the Utility of Access Recirculation and Kt/V for the Prediction of Arteriovenous Fistula Failure Using Online Clearance Monitoring: The SHUNT STUDY10.1007/s40620-022-01525-4 ↗
37. Multiple Determinants of Functional Patency of Autogenous Arteriovenous Fistulas: A Multicenter Prospective Study10.1016/j.jvs.2015.07.086 ↗
38. Construction of Risk-Prediction Models for Autogenous Arteriovenous Fistula Thrombosis in Patients on Maintenance Hemodialysis10.1159/000540543 ↗
39. Factors Influencing AVF Dysfunction in Patients with Maintenance Hemodialysis: A Retrospective Study10.21037/apm-20-2196 ↗
40. Risk Factors for Primary Arteriovenous Fistula Dysfunction in Hemodialysis Patients: A Retrospective Survival Analysis in Multiple Medical Centers10.1159/000500045 ↗